16-31483140-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_003041.4(SLC5A2):c.4G>A(p.Glu2Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,461,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003041.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC5A2 | NM_003041.4 | c.4G>A | p.Glu2Lys | missense_variant | 1/14 | ENST00000330498.4 | |
SLC5A2 | XM_006721072.5 | c.4G>A | p.Glu2Lys | missense_variant | 1/13 | ||
SLC5A2 | XM_024450402.2 | c.4G>A | p.Glu2Lys | missense_variant | 1/11 | ||
SLC5A2 | NR_130783.2 | n.18G>A | non_coding_transcript_exon_variant | 1/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC5A2 | ENST00000330498.4 | c.4G>A | p.Glu2Lys | missense_variant | 1/14 | 1 | NM_003041.4 | P1 | |
SLC5A2 | ENST00000419665.6 | c.4G>A | p.Glu2Lys | missense_variant, NMD_transcript_variant | 1/12 | 1 | |||
SLC5A2 | ENST00000569576.5 | c.-4+72G>A | intron_variant | 4 | |||||
SLC5A2 | ENST00000562006.1 | n.3G>A | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251178Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135822
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461700Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727138
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.4G>A (p.E2K) alteration is located in exon 1 (coding exon 1) of the SLC5A2 gene. This alteration results from a G to A substitution at nucleotide position 4, causing the glutamic acid (E) at amino acid position 2 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at